نتایج جستجو برای: thromboprophylaxis

تعداد نتایج: 1717  

2014
Pranab Sinha Ali-Asgar Najefi John Hambidge

Neck of femur (NOF) fractures are a major public health concern because of the ageing population and higher incidence of fragility fractures. NOF fractures are associated with high mortality and morbidity rates, and there is a high risk of venous thromboembolism (VTE) after hip fractures (Ref 1). Therefore thromboprophylaxis is vital. Current NICE guidelines advocate 28 - 35 days of thromboprop...

Journal: :Obstetrics and gynecology 2006
Holly Casele William A Grobman

OBJECTIVE To evaluate the cost-effectiveness of thromboprophylaxis at cesarean delivery with intermittent pneumatic compression. METHODS A decision tree model using Markov analysis was developed to compare two approaches to perioperative care at the time of cesarean delivery: 1) no use of perioperative thromboprophylaxis and 2) the use of intermittent pneumatic compression for thromboprophyla...

2018
Majed S Al Yami Sawsan Kurdi Ivo Abraham

Background Standard-duration (7-10 days) thromboprophylaxis with low molecular weight heparin, low dose unfractionated heparin, or fondaparinux in hospitalized medically ill patients is associated with ~50% reduction in venous thromboembolism (VTE) risk. However, these patients remain at high risk for VTE post-discharge. The direct oral anticoagulants (DOACs) apixaban, rivaroxaban and betrixaba...

Journal: :British journal of haematology 2007
Nienke Folkeringa Jan Leendert P Brouwer Fleurisca J Korteweg Nic J G M Veeger Jan Jaap H M Erwich Jozien P Holm Jan van der Meer

Hereditary thrombophilia is associated with an increased risk of fetal loss. Assuming that fetal loss is due to placental thrombosis, anticoagulant treatment might improve pregnancy outcome. In an observational family cohort study, we prospectively assessed the effects of anticoagulant drugs on fetal loss rates in women with hereditary deficiencies of antithrombin, protein C or protein S. The c...

2016
Eunyoung Lee Sung-Bum Kang Sang Il Choi Eun Ju Chun Min Jeong Kim Duck-Woo Kim Heung-Kwon Oh Myong Hoon Ihn Jin Won Kim Soo-Mee Bang Jeong-Ok Lee Yu Jung Kim Jee Hyun Kim Jong Seok Lee Keun-Wook Lee

PURPOSE Pharmacologic thromboprophylaxis is routinely recommended for Western cancer patients undergoing major surgery for prevention of venous thromboembolism (VTE). However, it is uncertainwhetherroutine administration of pharmacologic thromboprophylaxis is necessary in all Asian surgical cancer patients. This prospective study was conducted to examine the incidence of and risk factors for po...

Journal: :QJM : monthly journal of the Association of Physicians 2010
C Bagot S Gohil R Perrott S Barsam R K Patel R Arya

BACKGROUND Venous thromboembolism is a common condition in hospitalized medical patients. Numerous studies have demonstrated that low molecular weight heparin significantly reduces this risk but, despite this, the use of thromboprophylaxis remains poor. AIM To evaluate the use of an exclusion based risk-assessment model (RAM) for venous thrombosis in improving the uptake of appropriate thromb...

2013
Jin Won Kim Eun Ju Chun Sang Il Choi Do Joong Park Hyung-Ho Kim Soo-Mee Bang Min Jeong Kim Ju-Hee Lee Moon-Soo Lee Jeong-Ok Lee Yu Jung Kim Jee Hyun Kim Jong Seok Lee Keun-Wook Lee

Several Western guidelines recommend the routine use of pharmacologic thromboprophylaxis for cancer surgery patients to prevent venous thromboembolism (VTE). However, the necessity of routine pharmacologic perioperative thromboprophylaxis in Asian gastric cancer (GC) patients has not been clearly determined. To determine the necessity of routine perioperative pharmacologic thromboprophylaxis in...

Journal: :Journal of hospital medicine 2013
Carmen B Smith April C Hurdle Leonette O Kemp Christophe Sands Jennifer D Twilla

BACKGROUND The incidence of venous thromboembolism (VTE) in chronic liver disease (CLD) patients has been reported to be 0.5% to 6.3%. Studies report the use of thromboprophylaxis in CLD patients as suboptimal, with at least 75% of patients receiving no prophylaxis. OBJECTIVE To describe the use of VTE prophylaxis in CLD patients. DESIGN A retrospective review. SETTING Tertiary-care acade...

2017
Michael G. Fehlings Lindsay A. Tetreault Bizhan Aarabi Paul Anderson Paul M. Arnold Darrel S. Brodke Anthony S. Burns Kazuhiro Chiba Joseph R. Dettori Julio C. Furlan Gregory Hawryluk Langston T. Holly Susan Howley Tara Jeji Sukhvinder Kalsi-Ryan Mark Kotter Shekar Kurpad Brian K. Kwon Ralph J. Marino Allan R. Martin Eric Massicotte Geno Merli James W. Middleton Hiroaki Nakashima Narihito Nagoshi Katherine Palmieri Anoushka Singh Andrea C. Skelly Eve C. Tsai Alexander Vaccaro Jefferson R. Wilson Albert Yee James S. Harrop

Introduction The objective of this study is to develop evidence-based guidelines that recommend effective, safe and cost-effective thromboprophylaxis strategies in patients with spinal cord injury (SCI). Methods A systematic review of the literature was conducted to address key questions relating to thromboprophylaxis in SCI. Based on GRADE (Grading of Recommendation, Assessment, Development ...

Journal: :Postgraduate medical journal 2000
G M Taylor C A McKenzie G J Mires

An audit of the introduction of a protocol for thromboprophylaxis at caesarean section revealed over treatment of low risk women and the under treatment of high risk women. A routine computer generated risk assessment profile was introduced as part of a maternity information system. Reaudit showed a significant improvement in adherence to the thromboprophylaxis protocol in all risk groups.

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید